Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.
Baldus S, Köster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, Warnholtz A, Staude HJ, Thuneke F, Koss K, Berger J, Meinertz T, Freeman BA, Münzel T. Baldus S, et al. Among authors: ostad ma. Free Radic Biol Med. 2005 Nov 1;39(9):1184-90. doi: 10.1016/j.freeradbiomed.2005.06.004. Epub 2005 Aug 10. Free Radic Biol Med. 2005. PMID: 16214034 Free PMC article. Clinical Trial.
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease.
Warnholtz A, Ostad MA, Heitzer T, Thuneke F, Fröhlich M, Tschentscher P, Schwedhelm E, Böger R, Meinertz T, Munzel T. Warnholtz A, et al. Among authors: ostad ma. Atherosclerosis. 2007 Oct;194(2):439-45. doi: 10.1016/j.atherosclerosis.2006.08.034. Epub 2006 Sep 12. Atherosclerosis. 2007. PMID: 16970950 Clinical Trial.
A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study.
Warnholtz A, Ostad MA, Velich N, Trautmann C, Schinzel R, Walter U, Munzel T. Warnholtz A, et al. Among authors: ostad ma. Atherosclerosis. 2008 Feb;196(2):689-95. doi: 10.1016/j.atherosclerosis.2006.12.009. Epub 2007 Jan 9. Atherosclerosis. 2008. PMID: 17214996 Clinical Trial.
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
Warnholtz A, Wild P, Ostad MA, Elsner V, Stieber F, Schinzel R, Walter U, Peetz D, Lackner K, Blankenberg S, Munzel T. Warnholtz A, et al. Among authors: ostad ma. Atherosclerosis. 2009 May;204(1):216-21. doi: 10.1016/j.atherosclerosis.2008.08.003. Epub 2008 Aug 12. Atherosclerosis. 2009. PMID: 18822413 Clinical Trial.
Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study.
Ostad MA, Nick E, Paixao-Gatinho V, Schnorbus B, Schiewe R, Tschentscher P, Munzel T, Warnholtz A. Ostad MA, et al. Clin Res Cardiol. 2011 Jan;100(1):29-36. doi: 10.1007/s00392-010-0199-6. Epub 2010 Jul 21. Clin Res Cardiol. 2011. PMID: 20644943 Clinical Trial.
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Böger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A. Ostad MA, et al. Atherosclerosis. 2009 Jul;205(1):227-32. doi: 10.1016/j.atherosclerosis.2008.11.032. Epub 2008 Dec 9. Atherosclerosis. 2009. PMID: 19150064 Clinical Trial.
43 results